CCDC90A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.798400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.974000E-01
Normal-vs-Stage2
7.114000E-01
Normal-vs-Stage3
7.793800E-01
Normal-vs-Stage4
1.721980E-01
Stage1-vs-Stage2
6.029800E-01
Stage1-vs-Stage3
7.496000E-01
Stage1-vs-Stage4
2.273000E-01
Stage2-vs-Stage3
9.533600E-01
Stage2-vs-Stage4
2.598600E-01
Stage3-vs-Stage4
4.872200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.600200E-01
Normal-vs-AfricanAmerican
6.358400E-01
Normal-vs-Asian
8.635600E-01
Caucasian-vs-AfricanAmerican
8.599200E-01
Caucasian-vs-Asian
6.266600E-01
AfricanAmerican-vs-Asian
6.603200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.831400E-01
Normal-vs-Female
6.718400E-01
Male-vs-Female
8.318400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.708200E-01
Normal-vs-Age(41-60Yrs)
4.450800E-01
Normal-vs-Age(61-80Yrs)
8.425200E-01
Normal-vs-Age(81-100Yrs)
4.239600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.230400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.029200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.279200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.105500E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.500400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.480400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.455200E-01
Normal-vs-Daily Drinker
7.677600E-01
Normal-vs-Weekly Drinker
2.214200E-01
Normal-vs-Occasional Drinker
5.795800E-01
Normal-vs-Social Drinker
7.729800E-01
Non Drinker-vs-Daily Drinker
2.057800E-01
Non Drinker-vs-Weekly Drinker
1.026210E-01
Non Drinker-vs-Occasional Drinker
6.070600E-01
Non Drinker-vs-Social Drinker
7.193600E-01
Daily Drinker-vs-Weekly Drinker
3.823400E-03
Daily Drinker-vs-Occasional Drinker
9.248400E-02
Daily Drinker-vs-Social Drinker
2.966000E-01
Weekly Drinker-vs-Occasional Drinker
3.004000E-01
Weekly Drinker-vs-Social Drinker
4.083600E-02
Occasional Drinker-vs-Social Drinker
4.040200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.592200E-01
Normal-vs-Grade 2
9.322400E-01
Normal-vs-Grade 3
9.999200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.047770E-01
Grade 1-vs-Grade 3
5.166200E-01
Grade 1-vs-Grade 4
8.592200E-01
Grade 2-vs-Grade 3
2.748200E-01
Grade 2-vs-Grade 4
9.322400E-01
Grade 3-vs-Grade 4
9.999200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.538400E-01
Normal-vs-NonDiabetic
6.693800E-01
Diabetic-vs-NonDiabetic
9.920000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.995200E-01
Normal-vs-NoPancreatitis
6.640400E-01
Pancreatitis-vs-NoPancreatitis
7.154600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.561600E-01
Normal-vs-N1
6.855200E-01
N0-vs-N1
6.352800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.349400E-01
Normal-vs-TP53-NonMutant
9.769600E-01
TP53-Mutant-vs-TP53-NonMutant
1.335770E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
